BlackRock, Inc. 13D and 13G filings for Integra LifeSciences Holdings Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-07-08 4:32 pm Purchase | 2024-06-30 | 13G | Integra LifeSciences Holdings Corporation IART | BlackRock Inc. BLK | 11,253,404 14.300% | 4,611,559 (+69.43%) | Filing |
| 2024-01-25 1:48 pm Sale | 2023-12-31 | 13G | Integra LifeSciences Holdings Corporation IART | BlackRock Inc. BLK | 6,641,845 8.500% | -501,391 (-7.02%) | Filing |
| 2023-02-03 4:27 pm Purchase | 2022-12-31 | 13G | Integra LifeSciences Holdings Corporation IART | BlackRock Inc. BLK | 7,143,236 8.600% | 383,744 (+5.68%) | Filing |
| 2022-02-01 5:08 pm Purchase | 2021-12-31 | 13G | Integra LifeSciences Holdings Corporation IART | BlackRock Inc. BLK | 6,759,492 8.000% | 336,480 (+5.24%) | Filing |
| 2021-02-05 08:03 am Sale | 2020-12-31 | 13G | Integra LifeSciences Holdings Corporation IART | BlackRock Inc. BLK | 6,423,012 7.600% | -245,014 (-3.67%) | Filing |
| 2020-02-05 11:45 am Sale | 2019-12-31 | 13G | Integra LifeSciences Holdings Corporation IART | BlackRock Inc. BLK | 6,668,026 7.800% | -62,278 (-0.93%) | Filing |